Horizon Discovery Investor
Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.
Investors
.png)
Technology:
Others
Industry:
Longevity Industry 2022
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2007
Employees Number:
251-500
Funding Status:
M&A
Investor Type:
Investor
Number Of Exits:
Post-IPO Equity
Investors Number:
16
Total Funding:
$38.5M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership